High Quality Undervalued Stocks

Results

258

44 new
This selection of undervalued companies are the market's hidden engines of wealth. Not only do they combine good cash flows with and a solid balance sheet, but they are also poised for a breakout.

258 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MRK
US$130.20-0.7%64.2%US$320.6bUS$135.1936.021.2%2.6%Pharmaceuticals & Biotech
PLTR
US$123.060.1%-20.2%US$293.1bUS$182.20129.331.9%n/aSoftware
STX
US$855.910.5%452.9%US$193.3bUS$1,106.0961.030.1%0.3%Tech
AIR
€202.20-1.9%19.6%€161.5b€224.4626.914.7%1.6%Capital Goods
WDC
US$544.484.7%611.3%US$183.7bUS$655.5029.620.5%0.1%Tech
601138
CN¥56.70-5.9%71.8%CN¥1.1tCN¥90.4327.730.4%1.7%Tech
ENR
€146.80-3.0%49.9%€125.0b€199.0856.426.3%0.5%Capital Goods
2308
NT$1,640.00-8.1%178.9%NT$4.3tNT$2,487.6052.229.6%0.7%Tech
6098
JP¥12,550.004.1%38.1%JP¥17.4tJP¥13,018.7535.113.6%0.2%Commercial Services
MELI
US$1,877.954.2%-21.0%US$95.6bUS$2,214.8849.626.7%0%Retail
VRT
New
US$241.57-16.8%70.6%US$87.6bUS$343.1953.725.2%0.1%Capital Goods
6981
New
JP¥7,416.00-10.8%221.2%JP¥13.5tJP¥11,052.9457.724.2%0.9%Tech
4519
JP¥6,932.00-6.5%-5.6%JP¥11.4tJP¥9,686.6724.212.2%1.9%Pharmaceuticals & Biotech
SE
US$106.746.7%-30.8%US$65.1bUS$142.2640.824.0%n/aRetail
BE
New
US$205.8111.3%460.5%US$61.0bUS$273.51247.542.5%n/aCapital Goods
FIX
US$1,729.69-0.2%148.8%US$59.7bUS$2,210.8642.420.8%0.2%Capital Goods
A009150
₩1,142,000.00-13.9%696.9%₩84.2t₩2,471,111.11106.135.8%0.2%Tech
HO
€245.904.0%4.4%€50.0b€292.6733.816.3%1.6%Capital Goods
CIEN
US$377.05-3.6%325.4%US$52.7bUS$565.71121.830.4%n/aTech
2383
NT$4,745.00-0.2%323.7%NT$1.7tNT$6,896.6774.255.2%0.5%Tech
GALD
CHF 175.751.2%37.8%CHF 42.4bCHF 191.9483.124.3%0.2%Pharmaceuticals & Biotech
FITB
US$56.50-1.6%38.1%US$51.3bUS$62.901.622.1%2.8%Banks
COHR
New
US$262.89-6.9%155.8%US$48.7bUS$391.45128.447.5%n/aTech
FLEX
US$113.75-4.0%129.7%US$41.0bUS$160.5042.844.9%n/aTech
Page 1 of 8